One disclosed excipient, one specific and widely repeated claim about it. Not a general tour of what is in a capsule shell -- one claim, checked against one line on this label and the research behind it.
Prepared by the Sodatidedaily Editorial Desk · Medically reviewed by Dr. Pascale Carbonara, MD · Updated
Sodatide's other-ingredients line discloses magnesium stearate among four excipients: hypromellose (the vegetarian capsule shell), microcrystalline cellulose, magnesium stearate, and silica. A claim circulates widely in consumer supplement commentary that magnesium stearate “blocks nutrient absorption” or coats the gut in a way that prevents a capsule's active ingredients from being absorbed. The pharmaceutical literature on magnesium stearate does document a real, mechanistically understood effect: as a hydrophobic lubricant, it can coat drug particles during mixing and, in some tablet formulations and at some concentrations, measurably slow the in vitro dissolution rate of the tablet. That is a real, published finding. It is not the same claim as “blocks nutrient absorption in the gut,” and the gap between the two is the actual subject of this post.
Sodatide's Supplement Facts panel closes with an other-ingredients line reading: “Hypromellose (vegetarian capsule), microcrystalline cellulose, magnesium stearate, silica.” We transcribed the complete panel, including this line, on this site's own label page. All four are disclosed; none is hidden inside the Probiotic Blend or any other proprietary blend on this label.
Magnesium stearate is, functionally, a flow agent and lubricant. In capsule and tablet manufacturing, it is added in small amounts to keep powder blends from sticking to manufacturing equipment and to help capsules fill and close cleanly and consistently on a production line. It is one of the most commonly used excipients in the pharmaceutical and supplement industries, for exactly that reason.
This post is about one specific, widely repeated consumer claim about that one ingredient — not a general survey of excipients, and not a verdict on every criticism ever leveled at magnesium stearate. We are checking a single claim against the actual published research, because that is the claim we encounter most often about this line of this label.
In consumer-facing supplement commentary, the claim generally takes one of two related forms.
The stronger version holds that magnesium stearate coats the lining of the gut, forming a physical barrier that prevents nutrients from crossing into the bloodstream — sometimes described as “biofilm” formation or a generalized suppression of nutrient uptake throughout digestion. The milder version holds more specifically that magnesium stearate slows or reduces the breakdown and absorption of the active ingredients in the same capsule or tablet it is used in, making the product itself less effective.
Both versions trace back, at least in part, to real pharmaceutical science about how magnesium stearate behaves during manufacturing and in laboratory dissolution testing — which is exactly why the claim persists and is not simply invented from nothing. The question worth answering carefully is what that underlying research actually found, and whether it supports either version of the claim as commonly stated.
Magnesium stearate is hydrophobic — it repels water. During tablet and capsule manufacturing, it is typically blended with the other powdered ingredients immediately before compression or encapsulation, and because it is hydrophobic, it can form a thin coating over the surfaces of the other particles in the mix during that blending step. Pharmaceutical formulation science has studied this coating effect directly, because it has a real, measurable consequence: a hydrophobic coating on a tablet's particles can slow the rate at which water penetrates the tablet after it is swallowed, which in turn can slow the tablet's dissolution rate — how quickly it physically breaks apart and releases its contents into the digestive fluid.
A published study by Uzunović and Vranić, testing ranitidine hydrochloride coated tablets at varying magnesium stearate concentrations, found exactly this kind of effect: increasing magnesium stearate concentration in the tablet formulation was associated with a measurable slowing of the tablet's in vitro dissolution rate (Uzunović A, Vranić E. Effect of magnesium stearate concentration on dissolution properties of ranitidine hydrochloride coated tablets. Bosn J Basic Med Sci. 2007;7(3):279-283. PMID: 17848158). That is a real, peer-reviewed, mechanistically coherent finding, and it is the closest thing in the published pharmaceutical literature to the mechanism behind the consumer claim this post is checking.
It is also, on close reading, considerably narrower than the claim as commonly repeated. The study measured dissolution of a specific coated tablet formulation in a laboratory dissolution apparatus, at a range of magnesium stearate concentrations, for one specific drug. It did not measure, and was not designed to measure, whether nutrients from an unrelated ingredient are prevented from being absorbed across the human intestinal wall, and it did not test a capsule formulation of the kind used for Sodatide, where the mechanism of release (a dissolving capsule shell exposing a powder fill) differs from a compressed, coated tablet.
Sodatide discloses magnesium stearate on its other-ingredients line, alongside hypromellose, microcrystalline cellulose, and silica. All four are ordinary, common pharmaceutical and supplement excipients, and all four are properly disclosed on this label rather than hidden inside a blend.
Order NowRead the label firstThe distinction at the center of this fact-check is the difference between dissolution and absorption, and it is not a semantic technicality — it is the difference between what the published research actually measured and what the consumer claim asserts.
Dissolution is the physical process by which a solid dosage form breaks apart and its contents go into solution in the digestive fluid. It is a necessary precondition for absorption — a capsule's contents generally have to dissolve before they can be absorbed — but it is not the same process, and a measurable slowing of dissolution in a laboratory apparatus, at a given magnesium stearate concentration, in a given formulation, is not itself proof of reduced total absorption in a human being. A tablet or capsule that dissolves more slowly may still dissolve completely, given enough time in the gut, and deliver essentially the same total amount of its contents for absorption — simply over a somewhat longer window.
The strong version of the consumer claim — that magnesium stearate coats the gut lining itself and blocks absorption of nutrients broadly, including nutrients from food or other supplements taken separately — goes further still, asserting an effect on the intestinal wall rather than on the tablet or capsule's own dissolution. That version is not supported by the dissolution research cited above, which studied tablet behavior in a laboratory apparatus, not gut-wall interaction in a living person, and we are not aware of controlled human research establishing that a typical dietary supplement's magnesium stearate content meaningfully impairs whole-body nutrient absorption. Where evidence for a claim like that does not exist in the literature we have reviewed, the honest thing to write is that it does not exist — not to round an absent finding up to a confirmed one, and not to round a real, narrower dissolution finding up into the broader claim either.
Magnesium stearate is listed among substances Generally Recognized As Safe (GRAS) for use in food under FDA regulation (21 CFR 184.1440 lists magnesium stearate specifically as a GRAS food substance, usable with no limitation other than current good manufacturing practice), and it has a long history of use as a pharmaceutical and dietary supplement excipient at the small concentrations typically used for its lubricant function. Regulatory GRAS status is a statement about an ingredient's safety history and accepted use level, evaluated by a different process than the pharmaceutical dissolution research discussed above, and it is not, by itself, a rebuttal of a specific absorption claim — but it is relevant context, because a widely used, long-studied excipient with a documented safety record is a different starting point than an untested or novel additive would be.
It is also worth separating magnesium stearate's regulatory standing as a food and supplement excipient from a different question that occasionally gets folded into the same conversation: whether it is present as a plant-derived or animal-derived stearate. Magnesium stearate used in dietary supplement manufacturing is typically sourced from vegetable fats (commonly palm oil derivatives), though it can in principle be manufactured from animal fat as well, and a label is not required to specify the source unless an allergen or a specific claim, such as a vegetarian designation, depends on it. Sodatide's label identifies its capsule shell as a “vegetarian capsule” made of hypromellose, which is itself an unrelated, cellulose-derived material, but the label does not separately state the source of its magnesium stearate. That is a distinct disclosure question from the absorption claim this post is about, and we are not aware of anything in the material supplied to us that resolves it either way.
It is worth pausing on the mechanism by which a genuine, peer-reviewed pharmaceutical finding — a hydrophobic lubricant can slow a specific tablet's dissolution rate at certain concentrations — turns, through repetition in consumer health commentary, into a much broader and less supported claim about blocked nutrient absorption throughout the body.
The pattern is a common one in how technical findings travel outside the literature that produced them. A real result, true under specific, stated conditions (a particular tablet formulation, a particular concentration range, measured in a laboratory dissolution apparatus) gets summarized in a sentence that drops the conditions: “magnesium stearate slows dissolution” becomes “magnesium stearate blocks absorption.” Each restatement loses a qualifier, and the claim that eventually circulates is no longer the claim the original research supports, even though it is often presented alongside a citation to research that sounds, at a glance, like it backs the stronger version.
That pattern is exactly why this post treats the underlying pharmaceutical research and the popular claim as two different things to be checked separately, rather than assuming that because a related-sounding study exists, the full claim must be true. The Uzunović and Vranić finding is real and worth citing accurately, precisely because accurately citing it means being clear about what it did and did not measure.
Magnesium stearate's hydrophobic coating effect on tablet particles, and a resulting slowdown in laboratory dissolution rate at higher concentrations, is documented in the pharmaceutical literature for specific tablet formulations.
“Blocks nutrient absorption” asserts an effect on the gut wall and on whole-body nutrient uptake that the dissolution research does not test and does not establish.
Whatever a reader concludes about the claim, magnesium stearate is named on this label's other-ingredients line, not hidden. The disclosure itself is not in question.
Put plainly: this is not a claim we can confirm, and it is not a claim we can wave away as baseless nonsense either, because a real, narrower, peer-reviewed finding sits underneath it. The accurate summary sits between those two poles, and it is longer than either a flat yes or a flat no — which is exactly why the claim keeps circulating in its simpler, overstated form instead.
The bottle in your hand wins. If your own label's other-ingredients line differs from what is transcribed here, send us the photograph at [email protected] and we will correct this page and say that we did.
